ArticleFrontiers in microbiology2025
Identifying gut microbiota
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is a global health issue, with sharply increasing rates due to excessive food intake and reduced physical activity, leading to an increased risk of various chronic diseases, such as type 2 diabetes and cardiovascular diseases. Fat distribution plays a significant role in health, with visceral fat being particularly associated with metabolic syndrome. Currently, computed tomography (CT) and magnetic resonance imaging (MRI) are the gold standards for measuring visceral fat, but they are costly and involve radiation risks. The gut microbiota is closely related to obesity, and dysbiosis may lead to obesity and metabolic disorders. Research on the relationship between visceral fat and the gut microbiota can aid in the development of new diagnostic and therapeutic approaches. Methods: We selected 31 participants with class II obesity (body mass index between 35 and 40) and divided those samples into two groups on the basis of their VSR (visceral-to-subcutaneous fat volume ratio) measured by CT, analyzed their fecal. Microbiota through 16S rDNA sequencing. Results: Results reveal significant differences in microbial composition between the visceral and subcutaneous obesity groups through 16S analysis of their fecal microbiota. The visceral obesity group presented a greater abundance of the Conclusion: This study measured visceral and subcutaneous fat volumes via CT and revealed that the composition of the gut microbiota is related to the type of obesity. In addition, we found that
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.